A model-based approach to optimize detection of treatment effects in early oncology trials. This is an ASCO Meeting Abstract from the 2013 ASCO Annual Meeting I. This abstract does not include a full ...
Long-term survival results of a randomized multinational phase 3 trial of dacarbazine (DTIC) with or without Bcl-2 antisense (oblimersen sodium) in patients (pts) with advanced malignant melanoma (MM) ...
Markets Insider and Business Insider Editorial Teams were not involved in the creation of this post. Pasithea Therapeutics NewsMORE Indices Commodities Currencies Stocks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results